ADIPOQ and Alzheimer disease: Interestingly, despite these benefits, clinical studies have yielded conflicting results regarding plasma adiponectin levels in AD patients, with some reports indicating elevated levels in individuals with dementia, possibly reflecting a compensatory response to neurodegeneration or systemic inflammation [144,163,164,165].